Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and Entinostat in Metastatic Colorectal Cancer
NCT01105377Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of entinostat and azacitidine in metastatic colorectal cancer (mCRC), sponsored by National Cancer Institute. Primary endpoint: Confirmed Tumor Response at 6 months. Started Apr 2010; status: completed.
02
Drugs
entinostatazacitidine
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01105377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105377.